| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |